HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Case report of HbC/beta(0)-thalassemia from India.

Abstract
This 22-year-old women presented to the ante-natal clinic of this hospital for prenatal screening for beta-thalassemia. Cation exchange high performance liquid chromatography (HPLC) using 'Beta Thalassemia Short Program' on Bio-Rad 'Variant' system revealed HbC value of 81.6%. The CBC showed microcytic hypochromic anemia. The HPLC and CBC suggested the possibility of compound heterozygote state for HbC/beta-thalassemia. The alkali and acid electrophoresis findings were consistent with the above diagnosis. The DNA analysis confirmed compound heterozygote state for HbC/beta(0)-thalassemia (Fr 8/9 mutation). The studies on the parents showed that mother was a compound heterozygote for HbD(Punjab) and HbC while father had beta-thalassemia trait. To the best of our knowledge, this is the first confirmed report of HbC from India. The paper discusses the hematological findings in this subject and her mother (a compound heterozygote for HbD(Punjab) and HbC).
AuthorsS Kumar, M Rana, A Handoo, R Saxena, I C Verma, M Bhargava, S K Sood
JournalInternational journal of laboratory hematology (Int J Lab Hematol) Vol. 29 Issue 5 Pg. 381-5 (Oct 2007) ISSN: 1751-5521 [Print] England
PMID17824920 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Hemoglobins, Abnormal
  • hemoglobin D Punjab
Topics
  • Adult
  • Erythrocytes
  • Erythrocytes, Abnormal (chemistry)
  • Female
  • Hemoglobin C Disease (complications, genetics)
  • Hemoglobins, Abnormal (chemistry)
  • Humans
  • India
  • Infant, Newborn
  • Live Birth
  • Pedigree
  • Phenotype
  • Pregnancy
  • Pregnancy Complications, Hematologic
  • Prenatal Diagnosis
  • beta-Thalassemia (complications, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: